Energetics and function of the failing human heart with dilated or hypertrophic cardiomyopathy

European Journal of Clinical Investigation

Volumn 29, Issue 6, 1999, Pages 469-477

  Kalsi, K K ^a   Smolenski, R T ^a   Pritchard, R D ^a   Khaghani, A ^a   Seymour, A M L ^b   Yacoub, M H ^a,c  

^a National Heart and Lung Institute   (United Kingdom)

^b UNIVERSITY OF HULL   (United Kingdom)

^c HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

ATP; Citrate synthase; Dilated cardiomyopathy; Heart failure; Hypertrophic cardiomyopathy; Phosphocreatine

Indexed keywords

ADENINE NUCLEOTIDE; CITRATE SYNTHASE; CREATINE; CREATINE PHOSPHATE; GUANINE NUCLEOTIDE; LACTATE DEHYDROGENASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENERGY METABOLISM; ENZYME ACTIVITY; FEMALE; GLYCOLYSIS; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE METABOLISM; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL;

EID: 0033006277     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00468.x     Document Type: Article

References (44)

1. 1 Anderson PG, Allard MF, Thomas GD, Bishop SP, Digerness SB. Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts. Circ Res 1990; 67: 948-59.
2. 2 Gaasch WH, Zile MR, Hoshino PK, Weinberg EO, Rhodes DR, Apstein CS. Tolerance of the hypertrophic heart to ischemia. Studies in compensated and failing dog hearts with pressure overload hypertrophy. Circulation 1990; 81: 1644-53.
3. 3 Buser PT, Wikman Coffelt J, Wu ST, Derugin N, Parmley WW, Higgins CB. Postischemic recovery of mechanical performance and energy metabolism in the presence of left ventricular hypertrophy. A 31P-MRS study. Circ Res 1990; 66: 735-46.
4. 4 Katz AM. Pathophysiology of congestive heart failure. J Appl Cardiol 1990; 5: 427-30.
5. 5 Zhang J, Merkle H, Hendrich K, et al. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 1993; 92: 993-1003.
6. 6 Katz AM. Metabolism of the failing heart. Cardioscience 1993; 4: 199-203.
7. 7 Pool PE, Spann JF Jr, Buccino RA, Sonnenblick EH, Braunwald E. Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure. Circ Res 1967; 1: 365-73.
8. 8 Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991; 22: 795-801.
9. 9 Neubauer S, Horn M, Cramer M, et al. Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy. Circulation 1997; 6: 2190-6.
10. 10 Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK. Detection of low phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 1991; 38: 973-6.
11. 11 Swain JL, Sabina RL, Peyton RB, Jones RN, Wechsler AS, Holmes EW. Derangements in myocardial purine and pyrimidine nucleotide metabolism in patients with coronary artery disease and left ventricular hypertrophy. Proc Natl Acad Sci USA 1982; 9: 655-9.
12. 12 Seymour AM, Eldar H, Radda GK. Hyperthyroidism results in increased glycolytic capacity in the rat heart. A 31P-NMR study. Biochim Biophys Acta 1990; 1055: 107-16.
13. 13 Ingwall JS, Atkinson DE, Clarke K, Fetters JK. Energetic correlates of cardiac failure: changes in the creatine kinase system in the failing myocardium. Eur Heart J 1990; 11 (Suppl. B): 108-15.
14. 14 Schultheiss HP. Dysfunction of the ADP/ATP carrier as a causative factor for the disturbance of the myocardial energy metabolism in dilated cardiomyopathy. Basic Res Cardiol 1992; 87 (Suppl. 1): 311-20.
15. 15 Olsen EG. The pathology of cardiomyopathies. A critical analysis. Am Heart J 1979; 98: 385-92.
16. 16 Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 1988; 11: 416-26.
17. 17 Opie LH, Newsholme EA. The activities of fructose 1,6-diphosphatase, phosphofructokinase and phosphoenolpyruvate carboxykinase in white muscle and red muscle. Biochem J 1967; 103: 391-9.
18. 18 Morgan-Hughes JA, Darveniza P, Khan SN, et al. A mitochondrial myopathy characterized by a deficiency in reducible cytochrome b. Brain 1977; 100: 617-40.
19. 19 Wilson AC, Cahn RD, Kaplan NO. Functions of the two forms of lactic dehydrogenase in the breast muscle of birds. Nature 1963; 197: 331-4.
20. 20 Zammit VA, Newsholme EA. The maximum activities of hexokinase, phosphorylase, phosphofructokinase, glycerol phosphate dehydrogenases, lactate dehydrogenase, octopine dehydrogenase, phosphoenolpyruvate carboxykinase, nucleoside diphosphatekinase, glutamate-oxaloacetate transaminase and arginine kinase in relation to carbohydrate utilization in muscles from marine invertebrates. Biochem J 1976; 160: 447-62.
21. 21 Harmsen E, de Tombe PP, de Jong JW. Simultaneous determination of myocardial adenine nucleotides and creatine phosphate by high-performance liquid chromatography. J Chromatogr 1982; 230: 131-6.
22. 22 Smolenski RT, Lachno DR, Ledingham SJM, Yacoub MH. Determination of sixteen nucleosides, nucleotides and bases using high performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. J Chromatogr 1990; 527; 414-20.
23. 23 Savabi F. Free creatine available to the creatine phosphate energy shuttle in isolated rat atria. Proc Natl Acad Sci USA 1988; 85: 7476-80.
24. 24 Brunotte F, Peiffert B, Escanye JM, et al. Nuclear magnetic resonance spectroscopy of excised human hearts. Br Heart J 1992; 68: 272-5.
25. 25 Neubauer S, Krahe T, Schindler R, et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992; 86: 1810-8.
26. 31P magnetic resonance spectroscopy (Abstract). J Mol Cell Cardiol 1994; 26: 229.
27. 27 Nascimben L, Ingwall JS, Pauletto P, et al. Creatine kinase system in failing and nonfailing human myocardium. Circulation 1996; 94: 1894-901.
28. 28 Khuchua ZA, Vasiljeva EV, Clark JF, et al. The creatine kinase system and cardiomyopathy. Am J Cardiovasc Pathol 1992; 4: 223-34.
29. 29 Saks VA, Belikova YO, Kuznetsov AV, et al. Phosphocreatine pathway for energy transport: ADP diffusion and cardiomyopathy. Am J Physiol 1991; 261: 30-8.
30. 30 Peyton RB, Jones RN, Attarian, D et al. Depressed high-energy phosphate content in hypertrophied ventricles of animal and man: the biologic basis for increased sensitivity to ischemic injury. Ann Surg 1982; 196: 278-84.
31. 31 Sylven C, Jansson E, Book K. Key enzymes of myocardial energy metabolism in patients with valvular heart disease: relation to left ventricular function. Acta Physiol Scand 1988; 132: 267-70.
32. 32 Sylven C, Lin L, Jansson E, et al. Ventricular adenine nucleotide translocator mRNA is upregulated in dilated cardiomyopathy. Cardiovasc Res 1993; 27: 1295-9.
33. 33 Peters TJ, Brooksby IA, Webb Peploe MM, Wells G, Jenkins ES, Coltart DJ. Enzymic analysis of cardiac biopsy material from patients with valvular heart-disease. Lancet 1976; 1: 269-70.
34. 34 Wiener J, Giacomelli F, Loud AV, Anversa P. Morphometry of cardiac hypertrophy induced by experimental renal hypertension. Am J Cardiol 1979; 44: 919-29.
35. 35 Rakusan K, Tomanek RJ. Distribution of mitochondria in normal and hypertrophic myocytes from the rat heart. J Mol Cell Cardiol 1986; 18: 299-305.
36. 36 Schultheiss HP, Bolte HD, Fischer S, Cyran J. Enzymatic analysis and collagen content in endomyocardial biopsy samples of patients with congestive cardiomyopathy of unknown etiology. Clin Cardiol 1980; 3: 329-34.
37. 37 Schultheiss HP. Effect on the myocardial energy metabolism of angiotensin-converting enzyme inhibition in chronic heart failure. Am J Cardiol 1990; 65: 74G-81G.
38. 38 Barrie SE, Saad EA, Ubatuba S, Da Silva Lacaz P, Harris P. Myocardial enzyme activities in congestive cardiomyopathy. Res Commun Chem Pathol Pharmacol 1979; 23: 375-81.
39. 39 Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 1970; 218: 153-9.
40. 40 Katz EB, Stenbit AE, Hatton K, DePinho R, Charron MJ. Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 1995; 377: 151-5.
41. 41 Gordon A, Hultman E, Kaijser L, et al. Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 1995; 30: 413-8.
42. 42 Bartels GL, Remme WJ, Pillay M, et al. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. J Cardiovasc Pharmacol 1992; 20: 157-64.
43. 43 Schonekess BO, Allard MF, Lopaschuk GD. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 1995; 77: 726-34.
44. 44 Smolenski RT, Lachno DR, Yacoub MH. Adenine nucleotide catabolism in human myocardium during heart and heart-lung transplantation. Eur J Cardiothorac Surg 1992; 6: 25-30.